K. Mikkelsen

6.3k total citations
56 papers, 2.1k citations indexed

About

K. Mikkelsen is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, K. Mikkelsen has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Rheumatology, 19 papers in Immunology and 11 papers in Hematology. Recurrent topics in K. Mikkelsen's work include Rheumatoid Arthritis Research and Therapies (25 papers), Spondyloarthritis Studies and Treatments (18 papers) and Systemic Lupus Erythematosus Research (16 papers). K. Mikkelsen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Spondyloarthritis Studies and Treatments (18 papers) and Systemic Lupus Erythematosus Research (16 papers). K. Mikkelsen collaborates with scholars based in Norway, United States and Netherlands. K. Mikkelsen's co-authors include Tore K Kvien, C. Kaufmann, Wenche Koldingsnes, Marte Schrumpf Heiberg, E Rødevand, Erik Rødevand, Ivana Hollan, Petter Mowinckel, Johan F. Skomsvoll and S. Kalstad and has published in prestigious journals such as PLoS ONE, The Astrophysical Journal and Annals of the Rheumatic Diseases.

In The Last Decade

K. Mikkelsen

52 papers receiving 2.0k citations

Peers

K. Mikkelsen
Cédric Lukas France
Anders Jørgen Svendsen Denmark
Salahuddin Kazi United States
Tracy Y. Zhu Hong Kong
Victoria Navarro‐Compán Spain
Helga Radner Austria
Dorte Vendelbo Jensen Denmark
Carolyn Neville Canada
Linda T. Hiraki Canada
Þorvarður Jón Löve Iceland
Cédric Lukas France
K. Mikkelsen
Citations per year, relative to K. Mikkelsen K. Mikkelsen (= 1×) peers Cédric Lukas

Countries citing papers authored by K. Mikkelsen

Since Specialization
Citations

This map shows the geographic impact of K. Mikkelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Mikkelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Mikkelsen more than expected).

Fields of papers citing papers by K. Mikkelsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Mikkelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Mikkelsen. The network helps show where K. Mikkelsen may publish in the future.

Co-authorship network of co-authors of K. Mikkelsen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Mikkelsen. A scholar is included among the top collaborators of K. Mikkelsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Mikkelsen. K. Mikkelsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holm, Sverre, Tor‐Arne Hagve, Kjell Saatvedt, et al.. (2019). Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study. BMJ Open. 9(5). e030651–e030651. 7 indexed citations
2.
3.
Hollan, Ivana, Clett Erridge, David F. Lappin, et al.. (2014). Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis. PLoS ONE. 9(5). e98627–e98627. 11 indexed citations
4.
Hollan, Ivana, Manuela Nebuloni, Barbara Bottazzi, et al.. (2013). Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis. Cardiovascular Pathology. 22(5). 324–331. 14 indexed citations
5.
Fagerli, K. M., Elisabeth Lie, Désirée van der Heijde, et al.. (2013). Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study. Annals of the Rheumatic Diseases. 72(11). 1840–1844. 98 indexed citations
6.
Fagerli, K. M., Elisabeth Lie, Désirée van der Heijde, et al.. (2013). The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. Annals of the Rheumatic Diseases. 73(1). 132–137. 131 indexed citations
7.
Hjeltnes, Gunnbjørg, Ivana Hollan, Øystein Førre, et al.. (2012). Relations of Serum COMP to Cardiovascular Risk Factors and Endothelial Function in Patients with Rheumatoid Arthritis Treated with Methotrexate and TNF-α Inhibitors. The Journal of Rheumatology. 39(7). 1341–1347. 8 indexed citations
8.
Fagerli, K. M., E. Lie, Désirée van der Heijde, et al.. (2011). Predictors of ASDAS Major Improvement in Patients with Ankylosing Spondylitis Receiving Their First TNF Inhibitor. Results From a Longitudinal Observational Study. Data Archiving and Networked Services (DANS). 63(10). 4 indexed citations
9.
Wallenius, Marianne, Johan F. Skomsvoll, Lorentz M. Irgens, et al.. (2011). Fertility in women with chronic inflammatory arthritides. Lara D. Veeken. 50(6). 1162–1167. 58 indexed citations
10.
Breland, Unni M., Ivana Hollan, Kjell Saatvedt, et al.. (2010). Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. Lara D. Veeken. 49(6). 1118–1127. 23 indexed citations
11.
Lie, E., Désirée van der Heijde, Till Uhlig, et al.. (2010). Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register. Annals of the Rheumatic Diseases. 70(1). 157–163. 108 indexed citations
12.
Hollan, Ivana, Helge Scott, Kjell Saatvedt, et al.. (2007). Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: A controlled study of biopsy specimens obtained at coronary artery surgery. Arthritis & Rheumatism. 56(6). 2072–2079. 36 indexed citations
13.
Kvien, Tore K, Eirik Fjeld, B. Slatkowsky-Christensen, et al.. (2007). Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis. Annals of the Rheumatic Diseases. 67(7). 942–948. 51 indexed citations
14.
Heiberg, Marte Schrumpf, C. Kaufmann, E Rødevand, et al.. (2007). The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. Annals of the Rheumatic Diseases. 66(8). 1038–1042. 59 indexed citations
15.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). [Clinical use of COX inhibitors--a consensus].. PubMed. 126(5). 591–5. 5 indexed citations
16.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). Klinisk bruk av COX-hemmere – en konsensus. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
17.
Heiberg, Marte Schrumpf, Bjørn Yngvar Nordvåg, K. Mikkelsen, et al.. (2005). The comparative effectiveness of tumor necrosis factor–blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six‐month, longitudinal, observational, multicenter study. Arthritis & Rheumatism. 52(8). 2506–2512. 80 indexed citations
18.
Johnsen, Villy, Øystein Førre, Hans‐Jacob Haga, et al.. (2003). Kombinasjonsterapi ved revmatoid artritt. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
19.
Haga, Hans‐Jacob, et al.. (2000). Myalgi og høy senkning hos voksne. Tidsskrift for Den Norske Laegeforening.
20.
Magnus, Jeanette H., et al.. (1987). Toxicity to D-Penicillamine in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 16(6). 441–444. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cédric Lukas Breakdown of academic impact, for papers by Anders Jørgen Svendsen Breakdown of academic impact, for papers by Salahuddin Kazi Breakdown of academic impact, for papers by Tracy Y. Zhu Breakdown of academic impact, for papers by Victoria Navarro‐Compán Breakdown of academic impact, for papers by Helga Radner Breakdown of academic impact, for papers by Dorte Vendelbo Jensen Breakdown of academic impact, for papers by Carolyn Neville Breakdown of academic impact, for papers by Linda T. Hiraki Breakdown of academic impact, for papers by Þorvarður Jón Löve
Rankless by CCL
2026